Related Experiment Video
Updated: Jun 16, 2026

On-Chip Endothelial Inflammatory Phenotyping
Published on: July 21, 2012
KB-R7943 inhibits high glucose-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion
Jia Li1, Hong-Bo Jin, Yan-Ming Sun
1Department of Cardiac Care Unit, The First Affiliated Hospital of Harbin Medical University, and Department of Physiology, Harbin Medical University, Harbin 150001, China.
Abstract:
Hyperglycemia is the major cause of diabetic angiopathy. The aim of our study was to evaluate the impact of KB-R7943, an inhibitor of Na+/Ca2+ exchanger (NCX) on cell growth and function of human "diabetic" endothelial cells (EC). Intercellular adhesion molecule-1 (ICAM-1) expression and NCX activity were determined after EC were exposed to high glucose in the absence and presence of KB-R7943. Coincubation of EC with high glucose for 24 h resulted in a significant increase of monocyte-endothelial cell adhesion and the expression of ICAM-1. These effects were abolished by KB-R7943 and KB-R7943 significantly decreased the activation of NCX induced by high glucose. These findings suggested that KB-R7943 may play a role in inhibiting expression of adhesion molecules by inhibiting the reverse activation of NCX.
Insights
High glucose damages blood vessels by increasing cell adhesion. KB-R7943, a Na+/Ca2+ exchanger (NCX) inhibitor, reduced this damage in human endothelial cells, suggesting a therapeutic potential for diabetic angiopathy.
Area of Science:
- Cardiovascular Biology
- Endothelial Cell Function
- Diabetic Complications
Background:
- Hyperglycemia is a primary driver of diabetic angiopathy, leading to endothelial dysfunction.
- Endothelial cells (EC) play a crucial role in vascular health, and their dysfunction contributes to diabetic complications.
Purpose of the Study:
- To investigate the effect of KB-R7943, a Na+/Ca2+ exchanger (NCX) inhibitor, on human diabetic endothelial cells.
- To assess the impact of KB-R7943 on cell adhesion and intercellular adhesion molecule-1 (ICAM-1) expression under high glucose conditions.
Main Methods:
- Human endothelial cells were exposed to high glucose in the presence and absence of KB-R7943.
- Monocyte-endothelial cell adhesion assays were performed.
- Intercellular adhesion molecule-1 (ICAM-1) expression and Na+/Ca2+ exchanger (NCX) activity were measured.
Main Results:
- High glucose significantly increased monocyte-endothelial cell adhesion and ICAM-1 expression.
- KB-R7943 treatment abolished these high glucose-induced effects.
- KB-R7943 significantly reduced the high glucose-induced activation of NCX.
Conclusions:
- KB-R7943 demonstrates a protective effect against high glucose-induced endothelial cell activation and adhesion.
- Inhibition of NCX reverse activation by KB-R7943 may be a key mechanism in preventing diabetic angiopathy.
- KB-R7943 shows potential as a therapeutic agent for managing diabetic vascular complications.
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
